drugset / Trial / NCT06086327
Application of 68Ga-Pentixafor PET/CT for Thymoma
NaSingle-groupOpen-labelDiagnostic
Summary
Chemokine receptor CXCR4 was expressed in T cells and CXCR4-targeting molecular imaging- 68Ga-Pentixafor PET/CT could be a promising technique to evaluate the extent of thymoma with higher accuracy. This prospective study is going to investigate whether metabolic characterization by 68Ga-Pentixafor PET/CT may be superior for diagnosis, distinguish evaluation for thymoma.
Timeline
- Start
- 2023-06-22
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 68Ga-Pentixafor | Peptide | — | Intravenous |